1. Association for Molecular Pathology v. Myriad Genetics, Inc., No. 12–398 (U.S. June 13, (2013) .
2. BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair
3. Mayo Collaborative Services v. Prometheus Labs., Inc. 566 U.S. ( (2012) .
4. Henschel, R. F.US Supreme Court Casts Shadow on Personalized Medicine Patents.Science/Business, 29 March 2012.
5. Eisenberg, R. S.Prometheus Rebound, Diagnostics, Nature, and Mathematical Algorithms.122 Yale L.J. Online 2013, 341; seehttp://yalelawjournal.org/2013/04/01/eisenberg.html.